EW – edwards lifesciences corporation (US:NYSE)

DELAYED
$ usd
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day EW SPY QQQ SPX
Date
Time
Symbol
Company Name
Action
%Chg
10/24/2024
04:21 pm
ew
edwards lifesciences corporation
BEAT
-3.6%
7/24/2024
04:15 pm
ew
edwards lifesciences corporation
IN-LINE
-31.3%
4/25/2024
04:15 pm
ew
edwards lifesciences corporation
BEAT
-2.8%
2/6/2024
04:15 pm
ew
edwards lifesciences corporation
IN-LINE
-2.0%
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions?
The answers are right here.
Stock Stats
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
Top News Gainers
3/23 Form 4 Edwards Lifesciences For: Mar 23 Filed by: Szyman Catherine M. 17.6%
7/23 Q2/2019 6/30/2019 EPS 1.380 ZacksConsensus 1.320 ActVsEst 0.060 - Beat 9.8%
4/1 Form 4 Edwards Lifesciences For: Apr 01 Filed by: Lemercier Jean-Luc M 6.9%
3/9 Form 4 Edwards Lifesciences For: Mar 06 Filed by: BOBO DONALD E JR 6.2%
4/16 Form 4 Edwards Lifesciences For: Apr 16 Filed by: Szyman Catherine M. 5.0%
4/13 Form DEFA14A Edwards Lifesciences 4.9%
3/25 Form DEFA14A Edwards Lifesciences 4.5%
4/9 Edwards Lifesciences Corp (NYSE: EW) had its price target lowered by analysts at Raymond James from $263.00 to $230.00. They now have an "outperform" rating on the stock. 4.1%
10/25 Form 10-Q Edwards Lifesciences For: Sep 30 4.0%
2/3 Form 4 Edwards Lifesciences For: Feb 03 Filed by: Lemercier Jean-Luc M 3.7%
Top News Decliners
1/30 Form 8-K Edwards Lifesciences For: Jan 30 -10.6%
4/24 Edwards Lifesciences Corp (NYSE: EW) had its "buy" rating re-affirmed by analysts at Citigroup Inc. They now have a $255.00 price target on the stock, up previously from $240.00. -5.7%
3/20 Form 4 Edwards Lifesciences For: Mar 19 Filed by: MUSSALLEM MICHAEL A -5.1%
4/27 Edwards Lifesciences Corp (NYSE: EW) had its "underweight" rating re-affirmed by analysts at Barclays PLC. They now have a $155.00 price target on the stock, down previously from $165.00. -5.0%
10/24 Edwards Lifesciences Corp (NYSE: EW) had its "overweight" rating re-affirmed by analysts at Piper Jaffray Companies. They now have a $255.00 price target on the stock, up previously from $240.00. -4.0%
4/28 Edwards Lifesciences Corp (NYSE: EW) was downgraded by analysts at Wells Fargo & Co from an "overweight" rating to an "equal weight" rating. -3.5%
4/30 Form 4 Edwards Lifesciences For: Apr 30 Filed by: Szyman Catherine M. -3.1%
3/30 Form 4 Edwards Lifesciences For: Mar 30 Filed by: WANG HUIMIN -3.0%
9/6 Form 4 Edwards Lifesciences For: Sep 06 Filed by: BOBO DONALD E JR -2.7%
3/2 Form 4 Edwards Lifesciences For: Mar 02 Filed by: Wood Larry L -2.5%

Don’t Miss Out On The Next BIG Stock Move

Thanks for submitting the form.
EW – edwards lifesciences corporation (US:NASDAQ)
DELAYED
$ usd
1D
5D
1M
3M
YTD
1Y
3Y
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
EW
SPY
QQQ
SPX
EW – edwards lifesciences corporation (US:NASDAQ)
DELAYED
$ usd
1D
5D
1M
3M
YTD
1Y
3Y
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
EW SPY QQQ SPX
Stock Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
Stock Stats
Order Stats
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
News
11/22
01:23 pm
ew
Neutral
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW
11/22
01:15 pm
ew
Low
Investors With Losses Are Invited To Join The Schall Law Firm In A Fraud Case Against Edwards Lifesciences Corporation
11/22
12:15 pm
ew
Low
Investors who lost money on Edwards Lifesciences Corporation (EW) should contact Levi & Korsinsky about pending Class Action - EW
11/22
11:54 am
ew
Low
Faruqi & Faruqi Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 – EW
11/22
11:54 am
ew
Low
Faruqi & Faruqi Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 – EW
11/22
11:15 am
ew
Low
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky
11/22
11:00 am
ew
Low
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against Edwards Lifesciences Corporation
11/22
08:21 am
ew
Low
Despite delivering investors losses of 39% over the past 3 years, Edwards Lifesciences (NYSE:EW) has been growing its earnings [Yahoo! Finance]
11/22
08:00 am
ew
Low
Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
10/24/2024
04:21 pm
ew
-3.6%
BEAT
7/24/2024
04:15 pm
ew
-31.3%
IN-LINE
4/25/2024
04:15 pm
ew
-2.8%
BEAT
2/6/2024
04:15 pm
ew
-2.0%
IN-LINE
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions? The answers are right here.
10/30
06:46 am
Upgrades
Strong Sell
Hold
Sanford C. Bernstein
Low
-0.2%
10/25
12:49 pm
Maintains
Hold
Hold
Canaccord Genuity
Low
-1.2%
10/25
11:33 am
Maintains
Neutral
Neutral
JP Morgan
Low
-0.2%
10/25
08:16 am
Maintains
Neutral
Neutral
Baird
Low
-0.2%
10/25
08:16 am
Maintains
Neutral
Neutral
Baird
Low
-0.2%
10/11
08:41 am
Reiterates
Equal Weight
Morgan Stanley
Low
0.0%
10/11
08:41 am
Reiterates
Equal Weight
Morgan Stanley
Low
0.0%
10/11
08:32 am
Reinstates
Equal-Weight
Morgan Stanley
Low
-0.2%
10/11
08:32 am
Reinstates
Equal-Weight
Morgan Stanley
Low
-0.2%
11/13
06:16 pm
ew
Low
Form 4 Edwards Lifesciences For: Nov 13 Filed by: BOBO DONALD E JR
11/13
04:26 pm
ew
Low
Form 144 Edwards Lifesciences Filed by: BOBO DONALD E JR
11/8
10:35 am
ew
Low
Form SC 13G Edwards Lifesciences Filed by: WELLINGTON MANAGEMENT GROUP LLP
11/6
04:21 pm
ew
Low
Form 10-Q Edwards Lifesciences For: Sep 30
11/5
05:07 pm
ew
Low
Form 4 Edwards Lifesciences For: Nov 05 Filed by: Wood Larry L
11/5
04:11 pm
ew
Low
Form 144 Edwards Lifesciences Filed by: Wood Larry L
10/24
04:29 pm
ew
Medium
Form 8-K Edwards Lifesciences For: Oct 24
10/15
05:04 pm
ew
Low
Form 4 Edwards Lifesciences For: Oct 15 Filed by: BOBO DONALD E JR
10/4
02:15 pm
ew
Low
Form SC 13G/A Edwards Lifesciences Filed by: VANGUARD GROUP INC
Show more
Top News Gainers
3/23 Form 4 Edwards Lifesciences For: Mar 23 Filed by: Szyman Catherine M. 17.6%
7/23 Q2/2019 6/30/2019 EPS 1.380 ZacksConsensus 1.320 ActVsEst 0.060 - Beat 9.8%
4/1 Form 4 Edwards Lifesciences For: Apr 01 Filed by: Lemercier Jean-Luc M 6.9%
3/9 Form 4 Edwards Lifesciences For: Mar 06 Filed by: BOBO DONALD E JR 6.2%
4/16 Form 4 Edwards Lifesciences For: Apr 16 Filed by: Szyman Catherine M. 5.0%
4/13 Form DEFA14A Edwards Lifesciences 4.9%
3/25 Form DEFA14A Edwards Lifesciences 4.5%
4/9 Edwards Lifesciences Corp (NYSE: EW) had its price target lowered by analysts at Raymond James from $263.00 to $230.00. They now have an "outperform" rating on the stock. 4.1%
10/25 Form 10-Q Edwards Lifesciences For: Sep 30 4.0%
2/3 Form 4 Edwards Lifesciences For: Feb 03 Filed by: Lemercier Jean-Luc M 3.7%
Top News Decliners
1/30 Form 8-K Edwards Lifesciences For: Jan 30 -10.6%
4/24 Edwards Lifesciences Corp (NYSE: EW) had its "buy" rating re-affirmed by analysts at Citigroup Inc. They now have a $255.00 price target on the stock, up previously from $240.00. -5.7%
3/20 Form 4 Edwards Lifesciences For: Mar 19 Filed by: MUSSALLEM MICHAEL A -5.1%
4/27 Edwards Lifesciences Corp (NYSE: EW) had its "underweight" rating re-affirmed by analysts at Barclays PLC. They now have a $155.00 price target on the stock, down previously from $165.00. -5.0%
10/24 Edwards Lifesciences Corp (NYSE: EW) had its "overweight" rating re-affirmed by analysts at Piper Jaffray Companies. They now have a $255.00 price target on the stock, up previously from $240.00. -4.0%
4/28 Edwards Lifesciences Corp (NYSE: EW) was downgraded by analysts at Wells Fargo & Co from an "overweight" rating to an "equal weight" rating. -3.5%
4/30 Form 4 Edwards Lifesciences For: Apr 30 Filed by: Szyman Catherine M. -3.1%
3/30 Form 4 Edwards Lifesciences For: Mar 30 Filed by: WANG HUIMIN -3.0%
9/6 Form 4 Edwards Lifesciences For: Sep 06 Filed by: BOBO DONALD E JR -2.7%
3/2 Form 4 Edwards Lifesciences For: Mar 02 Filed by: Wood Larry L -2.5%